Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nikodem Skoczeń"'
Autor:
Marcin Olajossy, Michał Pająk, Nikodem Skoczeń, Rafał Mazur, Ewelina Soroka, Sebastian Masternak
Publikováno v:
Current Problems of Psychiatry, Vol 20, Iss 1, Pp 21-34 (2019)
Introduction: Smoking is a huge medical and social problem in Poland, with as many as about 24% of Poles being addicted to nicotine. Approximately 6 million people worldwide die every year from conditions that are closely related to tobacco addiction
Publikováno v:
Current Problems of Psychiatry, Vol 18, Iss 4, Pp 321-330 (2017)
New achievements within structural and functional imaging of central nervous system offer a basis for better understanding of the mechanisms underlying many mental disorders. In everyday clinical practice, we encounter many difficulties in the therap
Publikováno v:
Current Problems of Psychiatry, Vol 17, Iss 2, Pp 75-82 (2016)
The aim of the present study was to compare the concentrations of KYNA, 3-OH-KYN and the cytokines TNF-α and IL-6 in patients with depression vs. healthy controls as well as in patients with depression treated pharmacologically vs. those treated usi
Publikováno v:
Current Problems of Psychiatry, Vol 17, Iss 1, Pp 19-23 (2016)
Schizophrenic psychoses are a heterogeneous group of diseases that affect about 1% of the world’s population. The first symptoms of the disease usually manifest between ages 20 and 30. The diagnostic criteria for schizophrenia and its subtypes are
Autor:
Marcin Olajossy, Emilia Potembska, Sebastian Wnuk, Nikodem Skoczeń, Ewa M. Urbańska, Bartosz Olajossy
Publikováno v:
Psychiatria Danubina
Volume 30
Issue 3
Volume 30
Issue 3
Background Nowadays, depression is a serious clinical problem, as the prevalence of its various forms increases and there are growing numbers of patients with severe forms of depression and treatment-refractory depression. Depressed patients have bee
Publikováno v:
Current Issues in Pharmacy and Medical Sciences, Vol 28, Iss 2, Pp 105-110 (2015)
Normothymic, antidepressant and antipsychotic pharmaceutics are, in accordance with international guidelines, employed both in the therapy and the prevention of bipolar disorder (BD). Long-term studies on the mechanisms of action of such medications,